Ecstatic Integration

Ecstatic Integration

Christian Angermayer's balancing act

The biggest investor in psychedelics argues that psychedelics are very safe...but should only be taken under medical supervision. Is there a contradiction there?

Jules Evans's avatar
Jules Evans
Oct 30, 2022
∙ Paid
Peter Thiel-backed Atai snaps up Compass Pathways shares
Christian Angermayer, centre, at the $225m IPO of Atai in 2021

Christian Angermayer is a fascinating character. In the last two years, he has gone from an obscure biotech investor to the biggest and most prominent investor in psychedelics, and the leading figure in its transformation from hippy counterculture to Wall Street asset class.

In 2021, he took …

User's avatar

Continue reading this post for free, courtesy of Jules Evans.

Or purchase a paid subscription.
© 2025 The Challenging Psychedelic Experiences Project · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture